Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic dyslipoproteinemia].

H C Geiss1, K Parhofer

  • 1Medizinische Klinik I, Johannes-Gutenberg-Universität, Mainz. geiss@endokrinologie.klinik.uni-mainz.de

MMW Fortschritte Der Medizin
|May 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MMW Fortschritte der Medizin·2020
Same author

Complications and monitoring - Guidelines on Parenteral Nutrition, Chapter 11.

German medical science : GMS e-journal·2010
Same author

[Statines for all or individualized lipid lowering therapy?].

MMW Fortschritte der Medizin·2009
Same author

[Treatment of hyperlipidemia in the elderly].

MMW Fortschritte der Medizin·2009
Same author

Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins.

Atherosclerosis·2005
Same author

Effect of pioglitazone on lipids in well controlled patients with diabetes mellitus type 2 -- results of a pilot study.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association·2005

Diabetic dyslipoproteinemia, common in type 2 diabetes, involves abnormal lipid levels and increased cardiovascular risk. Management often requires medication beyond lifestyle changes to control triglycerides and cholesterol.

Area of Science:

  • Endocrinology and Metabolism
  • Cardiovascular Medicine
  • Lipidology

Context:

  • Diabetic dyslipoproteinemia is a key feature of type 2 diabetes mellitus and metabolic syndrome.
  • Pathogenesis involves insulin resistance, hyperglycemia, and abdominal obesity, leading to increased hepatic VLDL secretion.

Purpose:

  • To outline the characteristics and clinical implications of diabetic dyslipoproteinemia.
  • To discuss the management strategies for lipid abnormalities in diabetic patients.

Summary:

  • Characterized by elevated triglycerides and cholesterol, decreased HDL cholesterol, and altered LDL particle composition.
  • Contributes significantly to the heightened cardiovascular risk in diabetic individuals.
  • May also manifest as hypertriglyceridemia in type 1 diabetes mellitus.

Related Experiment Videos

Impact:

  • Highlights the link between dyslipidemia and cardiovascular complications in diabetes.
  • Emphasizes the need for pharmacological intervention when lifestyle modifications and glycemic control are insufficient.
  • Suggests statins, combination therapy, or fibrates as potential treatment options based on lipid profiles.